MOACM
PRAX icon

Mutual of America Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Mutual of America Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.17M Buy
15,432
+2,959
+24% +$937K 0.05% 422
2026
Q1 		$4.02M Buy
+12,473
New +$3.86M 0.05% 485

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Mutual of America Capital Management's PRAX Position: Q2 2026 in Review

Mutual of America Capital Management increased its Praxis Precision Medicines (PRAX) stake by 24% in Q2 2026, buying an estimated $937K and bringing the position to 15,432 shares worth $5.17M. The position accounts for 0.05% of the portfolio, ranked #422.

Mutual of America Capital Management first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Mutual of America Capital Management held 15,432 shares of Praxis Precision Medicines worth $5.17M as of Q2 2026.
  • Mutual of America Capital Management bought 2,959 Praxis Precision Medicines shares in Q2 2026, an estimated $937K.
  • Praxis Precision Medicines made up 0.05% of Mutual of America Capital Management's portfolio in Q2 2026, its #422 holding.
  • Mutual of America Capital Management first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 136 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.